“Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-Year Results from the POETYK PSO Program”. 2024. SKIN The Journal of Cutaneous Medicine 8 (2): s365. https://doi.org/10.25251/skin.8.supp.365.